These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32911053)

  • 1. Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?
    Bleijendaal H; Ramos LA; Lopes RR; Verstraelen TE; Baalman SWE; Oudkerk Pool MD; Tjong FVY; Melgarejo-Meseguer FM; Gimeno-Blanes FJ; Gimeno-Blanes JR; Amin AS; Winter MM; Marquering HA; Kok WEM; Zwinderman AH; Wilde AAM; Pinto YM
    Heart Rhythm; 2021 Jan; 18(1):79-87. PubMed ID: 32911053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.
    Groeneweg JA; van der Zwaag PA; Olde Nordkamp LR; Bikker H; Jongbloed JD; Jongbloed R; Wiesfeld AC; Cox MG; van der Heijden JF; Atsma DE; de Boer K; Doevendans PA; Vink A; van Veen TA; Dooijes D; van den Berg MP; Wilde AA; van Tintelen JP; Hauer RN
    Am J Cardiol; 2013 Oct; 112(8):1197-206. PubMed ID: 23871674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering and Visualizing Disease-Specific Electrocardiogram Features Using Deep Learning: Proof-of-Concept in Phospholamban Gene Mutation Carriers.
    van de Leur RR; Taha K; Bos MN; van der Heijden JF; Gupta D; Cramer MJ; Hassink RJ; van der Harst P; Doevendans PA; Asselbergs FW; van Es R
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e009056. PubMed ID: 33401921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy.
    van de Leur RR; de Brouwer R; Bleijendaal H; Verstraelen TE; Mahmoud B; Perez-Matos A; Dickhoff C; Schoonderwoerd BA; Germans T; Houweling A; van der Zwaag PA; Cox MGPJ; Peter van Tintelen J; Te Riele ASJM; van den Berg MP; Wilde AAM; Doevendans PA; de Boer RA; van Es R
    Heart Rhythm; 2024 Jul; 21(7):1102-1112. PubMed ID: 38403235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers.
    Lopes RR; Bleijendaal H; Ramos LA; Verstraelen TE; Amin AS; Wilde AAM; Pinto YM; de Mol BAJM; Marquering HA
    Comput Biol Med; 2021 Apr; 131():104262. PubMed ID: 33607378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Verstraelen TE; van Lint FHM; Bosman LP; de Brouwer R; Proost VM; Abeln BGS; Taha K; Zwinderman AH; Dickhoff C; Oomen T; Schoonderwoerd BA; Kimman GP; Houweling AC; Gimeno-Blanes JR; Asselbergs FW; van der Zwaag PA; de Boer RA; van den Berg MP; van Tintelen JP; Wilde AAM
    Eur Heart J; 2021 Jul; 42(29):2842-2850. PubMed ID: 34113975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation.
    Te Rijdt WP; van Tintelen JP; Vink A; van der Wal AC; de Boer RA; van den Berg MP; Suurmeijer AJ
    Histopathology; 2016 Oct; 69(4):542-50. PubMed ID: 26970417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms.
    Taha K; Te Rijdt WP; Verstraelen TE; Cramer MJ; de Boer RA; de Bruin-Bon RHACM; Bouma BJ; Asselbergs FW; Wilde AAM; van den Berg MP; Teske AJ
    JACC Cardiovasc Imaging; 2021 May; 14(5):885-896. PubMed ID: 33221241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholamban p.arg14del mutation in a Spanish family with arrhythmogenic cardiomyopathy: evidence for a European founder mutation.
    López-Ayala JM; Boven L; van den Wijngaard A; Peñafiel-Verdú P; van Tintelen JP; Gimeno JR
    Rev Esp Cardiol (Engl Ed); 2015 Apr; 68(4):346-9. PubMed ID: 25700660
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging.
    Te Rijdt WP; Ten Sande JN; Gorter TM; van der Zwaag PA; van Rijsingen IA; Boekholdt SM; van Tintelen JP; van Haelst PL; Planken RN; de Boer RA; Suurmeijer AJH; van Veldhuisen DJ; Wilde AAM; Willems TP; van Dessel PFHM; van den Berg MP
    Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):92-100. PubMed ID: 29635323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms.
    de Brouwer R; Meems LMG; Verstraelen TE; Mahmoud B; Proost V; Wilde AAM; Bosman LP; van Drie E; van der Zwaag PA; van Tintelen JP; Houweling AC; van den Berg MP; de Boer RA
    Heart Rhythm; 2022 Mar; 19(3):427-434. PubMed ID: 34767988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.
    Fish M; Shaboodien G; Kraus S; Sliwa K; Seidman CE; Burke MA; Crotti L; Schwartz PJ; Mayosi BM
    Sci Rep; 2016 Feb; 6():22235. PubMed ID: 26917049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
    van der Heide MYC; Verstraelen TE; van Lint FHM; Bosman LP; de Brouwer R; Proost VM; van Drie E; Taha K; Zwinderman AH; Dickhoff C; Schoonderwoerd BA; Germans T; Houweling AC; Gimeno-Blanes JR; van der Zwaag PA; de Boer RA; Cox MGPJ; van Tintelen JP; Wilde AAM
    Europace; 2024 Mar; 26(4):. PubMed ID: 38558121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy.
    Gho JM; van Es R; Stathonikos N; Harakalova M; te Rijdt WP; Suurmeijer AJ; van der Heijden JF; de Jonge N; Chamuleau SA; de Weger RA; Asselbergs FW; Vink A
    PLoS One; 2014; 9(4):e94820. PubMed ID: 24732829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy.
    van der Zwaag PA; van Rijsingen IA; de Ruiter R; Nannenberg EA; Groeneweg JA; Post JG; Hauer RN; van Gelder IC; van den Berg MP; van der Harst P; Wilde AA; van Tintelen JP
    Neth Heart J; 2013 Jun; 21(6):286-93. PubMed ID: 23568436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST).
    Te Rijdt WP; Hoorntje ET; de Brouwer R; Oomen A; Amin A; van der Heijden JF; Karper JC; Westenbrink BD; Silljé HHW; Te Riele ASJM; Wiesfeld ACP; van Gelder IC; Willems TP; van der Zwaag PA; van Tintelen JP; Hillege JH; Tan HL; van Veldhuisen DJ; Asselbergs FW; de Boer RA; Wilde AAM; van den Berg MP
    Neth Heart J; 2022 Feb; 30(2):84-95. PubMed ID: 34143416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.